Skip to main content
. 2019 Mar 25;10(3):312–323. doi: 10.1177/2192568219837923

Figure 6.

Figure 6.

VAS baseline scores compared to 48-month follow-up (−4.65 [95% CI: −5.51 to −3.79]; heterogeneity: I2 = 90.9%, P < .001).